Business activity and supply chain disruption caused by the spread of large-scale infectious diseases
First written in FY2021. 6 of 10 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
- FY2026MitigatedAnnual report
「In preparation for infectious disease outbreaks, our group is strengthening its health and hygiene management system under the overall supervision of the Risk Management Committee by establishing flexible working arrangements through telecommuting and online meetings, stockpiling masks, disinfectant and rapid test kits, and taking other measures.」
The response to infectious disease risk was made concrete through the Risk Management Committee, flexible work arrangements, and stockpiling hygiene products and testing kits. - FY2024MitigatedAnnual report
「We have established a dedicated BCP Crisis Management Office within the Company and formulated various BCPs (business continuity plans) addressing earthquakes, fires, cyberattacks, supply chain stoppages and other events.」
For the risks of business stoppages and supply chain disruption caused by infectious disease outbreaks and other events, specified measures involving a dedicated organization and the formulation of BCPs. - FY2023RestatedAnnual report
「Restrictions on economic activity in various countries due to the global spread of infectious diseases could result in the suspension of our group’s business activities and supply chain disruption on a global scale, potentially affecting the operating results and financial position of our group.」
Continues to disclose the risks of restrictions on economic activity, suspension of business activities and supply chain disruption caused by large-scale infectious diseases. - FY2023-Q3RestatedAnnual report
「There have been no material changes from the previous consolidated fiscal year in the assumptions, including the timing of the end of the COVID-19 pandemic, described in the “Additional Information” section of the securities report for the previous consolidated fiscal year under “Impact of COVID-19 on accounting estimates.”」
Reconfirmed that there had been no material changes from the previous fiscal year in the accounting assumptions, including the timing of the end of the COVID-19 pandemic. - FY2023-Q2RestatedAnnual report
「There have been no material changes from the previous consolidated fiscal year in the assumptions, including the timing of the end of the COVID-19 pandemic, described in the “Additional Information” section of the securities report for the previous consolidated fiscal year under “Impact of COVID-19 on accounting estimates.”」
Reconfirmed that there had been no material changes from the previous fiscal year in the accounting assumptions, including the timing of the end of the COVID-19 pandemic. - FY2022WorsenedAnnual report
「Lockdowns and other measures resulting from the spread of COVID-19 could cause supply chain disruption and lead to higher raw material and energy prices, and the outlook is expected to remain uncertain.」
For infectious disease risks, explicitly identified the potential knock-on effects of lockdowns, including supply chain disruption and higher raw material and energy prices, in addition to renewed infections. - FY2022-Q3RestatedAnnual report
「There have been no material changes from the previous consolidated fiscal year in the assumptions, including the timing of the end of the COVID-19 pandemic, described in the “Additional Information” section of the securities report for the previous consolidated fiscal year under “Impact of COVID-19 on accounting estimates.”」
Reconfirmed that there had been no material changes from the previous fiscal year in the accounting assumptions, including the timing of the end of the COVID-19 pandemic. - FY2022-Q2RestatedAnnual report
「There have been no material changes from the previous consolidated fiscal year in the assumptions, including the timing of the end of the COVID-19 pandemic, described in the “Additional Information” section of the securities report for the previous consolidated fiscal year under “Impact of COVID-19 on accounting estimates.”」
Reconfirmed that there had been no material changes from the previous fiscal year in the accounting assumptions, including the timing of the end of the COVID-19 pandemic. - FY2022-Q1RestatedAnnual report
「The global economy as a whole moved toward recovery as economic activity resumed with the spread of COVID-19 vaccines and through government economic stimulus measures. However, recovery was delayed in some countries due to renewed infections, and uncertainty about the outlook continues.」
While recognizing signs of an economic recovery due to the spread of vaccines and other factors, continued to identify the risk that renewed infections could delay the recovery and that uncertainty about the outlook would persist. - FY2021First statedAnnual report
「Restrictions on economic activity in various countries due to the global spread of infectious diseases could result in the suspension of our group’s business activities and supply chain disruption on a global scale, potentially affecting the operating results and financial position of our group.」
Added restrictions on economic activity, suspension of business activities and supply chain disruption caused by large-scale infectious diseases as new risk items. A sharp decline in orders and deterioration in business performance caused by the spread of COVID-19 occurred during the fiscal year.